Exome Asset Management LLC: PRAXIS PRECISION MEDICINES I (PRAX): Quarterly 13F Position History
As of Q2 2026, Exome Asset Management LLC reported 27,205 shares of PRAXIS PRECISION MEDICINES I (PRAX), worth $9.1M and representing 5.6% of its 13F equity book. Quarter-over-quarter share count change: 18,264 (-40.2%) . The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 27,205Shares Held (Latest Filing)
- $9.1MReported Market Value (Latest Filing)
- 5.6%Portfolio Weight (% of 13F Equity Book)
- 18,264Quarter-over-Quarter Share Change
- -$5.5MQuarter-over-Quarter Value Change
- 101,996Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 27,205 | 18,264 | -40.2% | $9.1M | 5.6% | $334.8 |
| Q1 2026 | 45,469 | 12,653 | -21.8% | $14.6M | 8.6% | $322.2 |
| Q4 2025 | 58,122 | 43,874 | -43.0% | $17.1M | 8.5% | $294.7 |
| Q3 2025 | 101,996 | +42,994 | +72.9% | $5.4M | 3.6% | $53.0 |
| Q2 2025 | 59,002 | – | – | $2.5M | 2.0% | $42.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Exome Asset Management LLC first disclose a PRAX position in 13F-HR filings?
Exome Asset Management LLC first reported PRAXIS PRECISION MEDICINES I (PRAX) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Exome Asset Management LLC's most recent quarter-over-quarter share-count change in PRAX?
Between Q1 2026 and Q2 2026, Exome Asset Management LLC reduced its PRAX position by 18,264 shares (-40.2%), leaving 27,205 shares at a market value of $9.1M.
Does the implied price-per-share represent Exome Asset Management LLC's cost basis in PRAX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.